Access
To read this article in full you will need to log-in or choose from the options on the right.
Distillery: Therapeutics - Ophthalmic disease
SciBX 2(42); doi:10.1038/scibx.2009.1579
Published online Oct. 29 2009
Extra navigation
LIM domain kinase 2 (LIMK2)
In vitro and mouse studies identified inhibitors of LIMK2 that could help treat ocular hypertension. Further details on the research, next steps and licensing status are discussed in the article.
To read this article in full you will need to log-in or choose from the options on the right.
